Algorithme Pharma Signs Strategic Alliance with University of Montreal Hospital Research Centre (CRCHUM)
(Laval, Québec, Canada Oct 29, 2013) – Algorithme Pharma is pleased to announce the signing of a strategic alliance with the University of Montreal Hospital Research Centre (CRCHUM), allowing for access to an extensive pool of patients and the new 520,000 sq. ft. research complex (CRCHUM) for conducting complex early stage clinical trials. This partnership will also provide access to CRCHUM's diverse research groups with extensive clinical research experience in therapeutic areas including Oncology, Neuroscience, Cardio-Metabolic Diseases and Respiratory Disorders.
The CRCHUM is a vast new research complex and embodies the openness and accessibility of its strategic location in downtown Montreal, Quebec. It includes a cyclotron, a state-of-the-art medical-imaging platform, 75 laboratories, 36 clinical examination rooms, 15 beds for early stage clinical trials, a specialized research pharmacy, as well as the Integrated Center for Education and Training (CIEF).
"The need for patient populations for early stage clinical trials continues to increase as drug development companies look for Proof of Concepts (POC) of their lead drug. This partnership will help advance the goal of providing a full spectrum of Phase I/IIa clinical research services in a diverse range of patient populations, to meet these growing needs" stated Dr. Marc Lefebvre, Vice-President Scientific & Regulatory Affairs, Algorithme Pharma Inc.
"We look forward to working with Algorithme Pharma closely and adding to our expertise in early stage clinical research. Working with a team focused on providing solutions to complex clinical issues in key therapeutic areas will allow us to stand out on the international drug development landscape" stated Dr. Jacques Turgeon, Director of the CRCHUM.
About Algorithme Pharma
Algorithme Pharma, an Altasciences Company, is a full service provider focused on early stage clinical research. With over 20 years' experience, Algorithme Pharma successfully completes more than 200 clinical trials annually. Support services include large and small molecule Bioanalysis, Data Management, Biostatistics, Regulatory Support, Clinical Pharmacology and Project Management.
About CRCHUM
The CRCHUM is the research arm of the University of Montreal Hospital. It improves the health of adults through a high-quality academic research continuum which, by improving our understanding of etiological and pathogenic mechanisms, fosters the development, implementation and assessment of new preventive, diagnostic and therapeutic strategies. The CRCHUM provides a training environment to ensure the development of new generations of researchers committed to research excellence.
Information:
Algorithme Pharma
Catherine Konidas
Vice-President Global Business Development
Tel.: 450-973-6077
[email protected] | www.algopharm.com
Centre Hospitalier de l'Université de Montréal (CHUM)
Dr. Paolo Renzi, FCCP FRCP(c)
Associate to the Director of Clinical Research, Phase I & II
Tel : (514) 890-8000 ext. 28031